company background image
GMED

Globus Medical NYSE:GMED Stock Report

Last Price

US$75.86

Market Cap

US$7.6b

7D

2.4%

1Y

17.2%

Updated

29 Jan, 2023

Data

Company Financials +

GMED Stock Overview

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

GMED fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 11.64% per year

Risk Analysis

No risks detected for GMED from our risk checks.

My Notes

New

Notes are coming soon

Globus Medical, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Globus Medical
Historical stock prices
Current Share PriceUS$75.86
52 Week HighUS$81.78
52 Week LowUS$52.60
Beta1.01
1 Month Change2.14%
3 Month Change13.22%
1 Year Change17.18%
3 Year Change45.10%
5 Year Change66.21%
Change since IPO461.93%

Recent News & Updates

Globus Medical: An Impressive Long-Term Revenue Growth Play

Jan 08

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Dec 22
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Dec 01
Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Recent updates

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Dec 22
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Dec 01
Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Oct 15
A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Sep 02
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Aug 11
Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

May 24
Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

May 06
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued

Mar 14
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued

Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest

Feb 24
Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest

Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Feb 08
Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jan 21
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Are Globus Medical, Inc. (NYSE:GMED) Investors Paying Above The Intrinsic Value?

Nov 28
Are Globus Medical, Inc. (NYSE:GMED) Investors Paying Above The Intrinsic Value?

Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

Nov 10
Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture

At US$76.32, Is Globus Medical, Inc. (NYSE:GMED) Worth Looking At Closely?

Oct 19
At US$76.32, Is Globus Medical, Inc. (NYSE:GMED) Worth Looking At Closely?

Globus Medical (NYSE:GMED) Is Reinvesting At Lower Rates Of Return

Aug 07
Globus Medical (NYSE:GMED) Is Reinvesting At Lower Rates Of Return

At US$78.13, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List?

Jul 20
At US$78.13, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List?

Calculating The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Jul 02
Calculating The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

It May Be Possible That Globus Medical, Inc.'s (NYSE:GMED) CEO Compensation Could Get Bumped Up

May 28
It May Be Possible That Globus Medical, Inc.'s (NYSE:GMED) CEO Compensation Could Get Bumped Up

Globus Medical (NYSE:GMED) Could Be Struggling To Allocate Capital

May 04
Globus Medical (NYSE:GMED) Could Be Struggling To Allocate Capital

Is It Time To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Apr 13
Is It Time To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Globus Medical, Inc. (NYSE:GMED) Shares Could Be 34% Above Their Intrinsic Value Estimate

Mar 23
Globus Medical, Inc. (NYSE:GMED) Shares Could Be 34% Above Their Intrinsic Value Estimate

Are Globus Medical, Inc.'s (NYSE:GMED) Mixed Financials Driving The Negative Sentiment?

Mar 05
Are Globus Medical, Inc.'s (NYSE:GMED) Mixed Financials Driving The Negative Sentiment?

The Globus Medical (NYSE:GMED) Share Price Has Gained 190%, So Why Not Pay It Some Attention?

Feb 16
The Globus Medical (NYSE:GMED) Share Price Has Gained 190%, So Why Not Pay It Some Attention?

Has Globus Medical (NYSE:GMED) Got What It Takes To Become A Multi-Bagger?

Jan 29
Has Globus Medical (NYSE:GMED) Got What It Takes To Become A Multi-Bagger?

Shareholder Returns

GMEDUS Medical EquipmentUS Market
7D2.4%-0.2%2.8%
1Y17.2%-9.7%-9.2%

Return vs Industry: GMED exceeded the US Medical Equipment industry which returned -9.7% over the past year.

Return vs Market: GMED exceeded the US Market which returned -9.2% over the past year.

Price Volatility

Is GMED's price volatile compared to industry and market?
GMED volatility
GMED Average Weekly Movement4.7%
Medical Equipment Industry Average Movement8.8%
Market Average Movement6.9%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market2.8%

Stable Share Price: GMED is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: GMED's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20032,400Dan Scavillahttps://www.globusmedical.com

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants.

Globus Medical, Inc. Fundamentals Summary

How do Globus Medical's earnings and revenue compare to its market cap?
GMED fundamental statistics
Market CapUS$7.57b
Earnings (TTM)US$155.21m
Revenue (TTM)US$998.37m

48.8x

P/E Ratio

7.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GMED income statement (TTM)
RevenueUS$998.37m
Cost of RevenueUS$254.93m
Gross ProfitUS$743.44m
Other ExpensesUS$588.23m
EarningsUS$155.21m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.55
Gross Margin74.47%
Net Profit Margin15.55%
Debt/Equity Ratio0%

How did GMED perform over the long term?

See historical performance and comparison